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Abstract
Background: Alzheimer's disease is the leading cause of dementia and affects about 25 million
people worldwide. Recent studies have evaluated the effect of early interventions for dementia, but
few studies have considered private time and transportation costs associated with the intervention.
This study assessed the total economic costs associated with a multifaceted intervention for mild
Alzheimer's disease, including an estimate of the ratio of public to private costs.
Methods: The study sample comprised 163 dyads of patients and caregivers who received a
multifaceted intervention of counselling sessions, courses and informational packages. The typical
duration of the intervention was 7 months. A micro-costing approach was applied using
prospectively collected data on resource utilisation that included estimates of participant time and
transportation. Precision estimates were calculated using a bootstrapping technique and structural
uncertainty was assessed with sensitivity analysis.
Results: The direct intervention cost was estimated at EUR 1,070 (95% CI 1,029;1,109). The total
cost (including private costs) was estimated at EUR 2,020 (95% CI 1,929;2,106) i.e. the ratio of
private to public costs was almost 1:1.
Conclusion: Intervention for mild Alzheimer's disease can be undertaken at a relatively low cost
to public funds. However, policy planners should pay attention to the significant private costs
associated with an intervention, which may ultimately pose a threat to equity in access to health
care.
Trial registration: Current Controlled Trials ISRCTN74848736.
Background
Recent estimates suggest that 24.3 million people world-
wide have dementia and that every year 4.6 million new
cases occur [1]. The prevalence of dementia has thus been
significantly underestimated and its incidence will
increase in the coming years due to demographic shift [2].
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Alzheimer's disease (AD) is the leading cause of dementia,
accounting for more than half of the cases [3].
The cost of care for people with dementia, sometimes
divided into the cost of formal care and that of informal
care, is related to the stage of disease. The UK combined
annual 2005/6 costs for people with dementia living in
the community were estimated at £16,689, £25,877 and
£37,473 per person for mild, moderate and severe demen-
tia, respectively [4]. US estimates are generally higher but,
due to methodological differences, wide variation is dem-
onstrated across studies [5,6]. None of these studies
included valuation of reduced quality of life experienced
by the person with dementia or the caregiver, i.e. cost esti-
mates represent minimum values.
Dementia is a chronic condition and intervention typi-
cally aims at slowing down disease progress and improv-
ing quality of life for the person with dementia. However,
dementia affects not only the patient but also the caregiv-
ers, who are often family members or others close to the
patient [7]. The gradual loss of the patient's cognitive abil-
ity exerts a significant emotional strain on the caregiver,
and this can have implications for the caregiver's social or
working life [6,8]. From both clinical and health eco-
nomic perspectives, therefore, it is important that inter-
ventions for dementia take into account effects on
caregivers.
The rationale for early intervention in dementia is clear,
but there is no apparent gold standard for the most appro-
priate approach. Current proposals include training and
education programmes, information and technology-
based support including specialised computer and tele-
phone networks, and more formal approaches to plan-
ning care [9]. Some of these have been assessed for
economic efficiency and found to be cost effective [10-13]
but none have included the resource category of partici-
pant time, i.e. the time required from participants to
attend therapeutic regimens. This need not be vital when
providing decision-makers with a foundation for priori-
tizing resources under the objective of allocative efficiency
but, when prioritizing resources under the additional
objective of equity in access to care, the burden of private
costs becomes highly relevant [14].
Even in a publicly financed health care system, users are
faced with copayment due to transportation costs, out-of-
pocket costs and the opportunity cost of their time spent
receiving therapy. These costs, ceteris paribus, increase
with the duration and intensity of a therapeutic regimen
and are further increased if the regimen is targeted to mul-
tiple parties e.g. patients and caregivers. Costs to private
parties associated with interventions for mild AD thus
pose a challenge to health policy planning in that the
implementation of new interventions may have detrimen-
tal effects on equity; less resourceful patients or caregivers
may decline participation due to excessive private costs or,
if accepting therapy, they may experience significant
financial strain. This consequence has been neglected in
the AD literature [15].
This paper assesses intervention costs of a best-bet-inter-
vention in mild AD using a micro-costing approach to
facilitate precise estimation of public and private costs. It
should not be confused with the literature assessing the
extent or interrelationship of formal and informal costs.
This study takes a narrower view of the extent of copay-
ment in a population that is particularly vulnerable due to
the nature of the therapeutic regimen - which is often long
term and requires time and input from caregivers. The aim
of this study was to assess the total economic costs of a
multifaceted intervention in mild AD, as well as the ratio
of public to private costs.
Methods
Sample and study design
The study sample of 163 dyads of patients and their car-
egivers was selected from a multi-centre, randomised,
controlled trial examining the efficacy of multifaceted
intervention aimed at patients and their caregivers. The
study sample included participants assigned to the inter-
vention arm only, as the control group received no inter-
vention. The trial was conducted across five (out of 15)
Danish county districts. Inclusion criteria comprised age ≥
50 years, a recent diagnosis of AD (within the past 12
months), Mini Mental State Examination (MMSE) score ≥
20, and having a primary caregiver who was willing to par-
ticipate in the study. The diagnosis of dementia was deter-
mined in consensus with fourth edition of the The
Diagnostic and Statistical Manual of Mental Disorders
[16] and the subtype of AD was determined using the
NINCDS-ADRDA criteria [17]. Exclusion of patients with
Lewy body disease was based on the McKeith criteria [18].
Furthermore, institutionalised patients and patients with
severe comorbidity were excluded. The present study is
thus a cohort study following persons with AD and their
caregivers from the first contact they had as part of the
intervention (initial meeting) to the last follow-up (final
meeting), which typically took place six to twelve months
after the initial meeting. The first study patients presented
in January 2004 and the final follow-up visit was in June
2006.
Intervention
A multifaceted intervention was designed with the objec-
tive of preventing or reducing depressive symptoms,
impairments of health-related quality of life and loss of
social network. The philosophy was to focus on positive
resources, intact functions and retained skills, and activi-BMC Health Services Research 2009, 9:215 http://www.biomedcentral.com/1472-6963/9/215
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ties that patients could still participate in. The following
sections describe key components of the intervention.
Counselling
A series of five counselling sessions, comprising both indi-
vidual sessions and group participation, was scheduled.
Counselling was based on constructivist principles [19]
and supported by the use of written notes, that were estab-
lished at the initial meeting and used to focus follow-up
sessions, according to Ishiayma's ideas on self-validation
[20]. A designated nurse undertook all counselling ses-
sions after receiving specialised training in the constructiv-
ist approach. In addition to face-to-face time, the
counsellor had an average preparation time of 30 minutes
before an initial meeting and 10 minutes before a follow-
up meeting. Participating study centres decided individu-
ally whether counselling was undertaken in the patient's
home or at the centre; approximately one-third of the ses-
sions took place in the patients' homes.
Courses
Two parallel lines, each of five courses, were aimed at
patients and caregivers, respectively. The objective was to
provide basic knowledge about dementia and its conse-
quences as well as to establish a forum for patients and
caregivers to exchange experiences and coping strategies.
Patient-targeted courses included written and oral infor-
mation on key issues about dementia and its conse-
quences. Caregiver-targeted courses included more formal
education about AD, supplemented by written informa-
tion. All courses were scheduled for 12 participants per
session and were run by one counsellor and one invited
teacher. Patient-targeted courses were additionally staffed
by two volunteers, who assisted the professionals during
the courses. Course duration was fixed at two hours (with
an additional 30 minutes of preparation time for the
counsellor).
Telephone counselling
At inclusion into the study, patients and caregivers were
informed that the intervention would include a regular
telephone call from the counsellor (approximately five to
eight times in intervals of three to four weeks) to ensure
regular contact and to follow up on issues discussed in
individual counselling sessions. Patients and caregivers
were asked to decide who should receive the telephone
calls; this could be either or both parties.
Handbook and Logbook
A comprehensive handbook about dementia was com-
posed for the study; one part was targeted patients and the
other caregivers. The handbook contained chapters on
causes of dementia, legal aspects in relation to living with
dementia, and sources and contacts for social support.
The handbook included a logbook section to encourage
patients and caregivers to write about their daily lives and
activities. However, since only six patients and seven car-
egivers did so, this information was not included in the
present analysis.
Concordance
The intervention comprised a range of components that
participants could choose to take advantage of. Participa-
tion was thus a result of the counsellor's assessment of
individual needs and preferences in collaboration with
the participant's (patient, caregiver, network) wishes. The
term 'compliance' was thus avoided and replaced by the
term 'concordance' to emphasise that target participation
rates were not necessarily 1.00. Concordance is typically
defined as adherence to an agreed schedule rather than
adherence to a fixed regimen.
Costing
The intervention was costed from a societal perspective,
including the costs of both formal and informal time of
the persons involved, and based on concurrent data col-
lection on resource utilisation.
The costs of developing or implementing the intervention
were not included in the present analysis, which should
be seen as estimating long-term average costs of imple-
menting the intervention in routine practice. As the inter-
vention was designed as a flexible framework from which
a tailored course could be set for each dyad, the cost anal-
ysis was conducted as a per-protocol analysis with service
utilisation counting only if it did in fact occur.
A case report form - administered by the counsellor - was
used to register the time (minutes) spent by professional
staff, the patient, the caregiver and the patient's network
across the scheduled activities of the intervention: coun-
selling, telephone counselling and courses. A load-factor
of 1.56 was applied to the cost of counselling to account
for non-productive time, i.e. effective confrontation time
was assumed to amount to, on average, 45 minutes of an
hour (load of 0.25) due to pauses, walking distance
between locations, private time etc. The remainder load
(0.31) was based on internal statistics on absence from
work due to vacation, sickness etc.
Valuation of formal care was based on gross market wage
rates from national collective agreements between Danish
local government and the respective professional associa-
tions except for teaching activity at courses, which was val-
ued using market prices. An overhead rate of 20% was
applied to account for capital costs.
Valuation of informal time, i.e. time spent by patients,
caregivers and networks participating in the intervention,
was undertaken using the opportunity cost method, inBMC Health Services Research 2009, 9:215 http://www.biomedcentral.com/1472-6963/9/215
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which the value of a person's time is reflected by his or her
wage rate. National average gender- and age-matched sal-
aries were used; for valuing leisure time the net salary was
used and for valuing productive time the gross salary was
used (both available from http://statistikbanken.dk
[21]). Transportation costs in relation to counselling ses-
sions in the patients' homes were applied as an average
base cost for all sessions, representing 20 minutes of time
and 10 kilometres each way. Similarly, participants' trans-
portation costs were applied as an average base cost of 30
minutes of time and 15 kilometres each way for all con-
tacts. The governmental tariff for transportation by private
car was used and it was further assumed that patients, car-
egivers and/or network participants shared one car. Item
costs not available in 2008 prices were inflated using the
general price index. Table 1 lists the item costs used.
Statistical analysis
Baseline characteristics of patients and caregivers were
described using conventional parametric statistics and
simple frequencies with percentage proportions. All other
reported estimates are arithmetic means with 95% bias-
corrected, bootstrapped confidence intervals (95% CIs)
from a non-parametric bootstrap distribution, which was
estimated from 1,000 extract replications from the origi-
nal sample (n = 163). The technique of bootstrapping is a
resampling technique that is appropriate for estimating
confidence intervals in the presence of e.g. positively
skewed data [22]. Statistical analyses were conducted
using STATA version 10.0 (StataCorp, Texas).
Ethics
The trial was conducted in accordance with the Helsinki
declaration and was approved by the local ethics commit-
tee. All patients and caregivers provided written informed
consent.
Results
Baseline characteristics
A total of 163 dyads were included, but only 157 dyads
received the intervention; three dyads dropped out due to
the intervention being too demanding for caregivers, one
dyad dropped out due to the intervention being too
demanding for the patient, one dyad dropped out because
the patient was hospitalised due to comorbidity, and one
dyad dropped out because the patient died before the
intervention started.
All patients were non-institutionalised persons with a
mild form of AD, as indicated by a mean MMSE score of
24 (SD 2). Mean age was 76 (SD 8) years with an almost
equal distribution between genders. Baseline characteris-
tics are further detailed in Table 2. Caregivers were charac-
terised by a mean age of 65 (SD 13) years, a gender
distribution with 66% women and a health-related qual-
ity of life of 0.83 (SD 0.17), which is comparable to an
age- and gender-matched population norm. Nearly 60%
were pensioners and approximately one-third were
employed. The caregivers were typically the patient's
spouse or son/daughter (in-law).
Concordance
The participation rates (Table 3) were unexpectedly high,
given the intervention's long duration, the many sched-
uled contacts and the associated transportation times and
costs. Thus 88% of patients and 91% of caregivers partici-
pated in at least three counselling sessions, while 81% of
patients and 80% of caregivers participated in at least
Table 1: Item costs used for estimating the costs of a support programme for mild Alzheimer's disease. 
Resource Cost Source
Time costs of formal care
Counsellor (specially trained nurse) 25.93 Local Government Denmark [KL]
Load-factor for counsellor's time [weight]1 1.56 Local Government Denmark [KL]/estimate
Course teacher, nurse [per course] 131.69 Market prices (tariff of trial management)
Course teacher, academic [per course] 219.48 Market prices (tariff of trial management)
Volunteers assisting course personnel 17.73 National average net salary for 50-year olds
Capital costs 20% Local Government Denmark [KL]
Time costs of informal time (examples)2
Male, 50-54 years, gross 32.50 Statistics Denmark
Male, 50-54 years, net 19.76 Statistics Denmark
Female, 50-54, gross 23.40 Statistics Denmark
Female, 50-54, net 15.70 Statistics Denmark
Transportation cost professionals [EUR/km] 0.25 Danish Government
Transportation cost participant [EUR/km] 0.47 Danish Government
1A load factor was applied to account for non-productive time of a counsellor due to pauses, walking distance between locations, private time, 
vacation and other absence from work etc. 2A complete set of age- and gender-specific national average salaries was used (complete data are 
publicly available from StatBank Denmark at http://statistikbanken.dk).
All costs are in 2008 EUR per hour unless otherwise stated.BMC Health Services Research 2009, 9:215 http://www.biomedcentral.com/1472-6963/9/215
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three courses. While only one session (the network meet-
ing) was aimed directly at patients' networks, these people
were welcome to attend the other meetings and sessions;
this opportunity was rarely used, however.
Resource utilisation
Table 4 details the estimated resource utilisation per
patient (ex capital costs) of the intervention. Constructiv-
ist counselling included five types of sessions: the first
three were scheduled as individual sessions for patients
and caregivers, respectively, while the last two were sched-
uled as combined sessions for patients, caregivers and net-
works. Overall, the constructivist counselling activity used
almost 6 1/2 hours of counsellor time, 2 1/2 hours of
patient time and 2 1/2 hours of caregiver time. Network
time amounted to an average of 42 minutes due to low
participation rates.
Table 2: Baseline characteristics of the study population of patients with mild Alzheimer's disease and their primary caregiver.
Patient (n = 157) Caregiver (n = 157)
Age, mean (SD) 76 (8) 65 (13)
Females, n (%) 85 (54) 104 (66)
Living alone (%) 53 (34) 22 (14)
MMSE score, mean (SD) 24 (2) NA
EQ-5D score (self-assessed), mean (SD) 0.85 (0.17) 0.83 (0.17)
Occupational status, n (%)
On pension 148 (94) 92 (59)
On early retirement 4 (3) 10 (6)
Working 3 (2) 49 (31)
Other (e.g. housewife) 2 (1) 6 (4)
Caregiver's relation to patient, n (%)
Spouse NA 99 (63)
Son/daughter (in-law) NA 48 (31)
Other NA 10 (6)
MMSE = Mini Mental State Examination. NA = Not applicable. EQ-5D = EuroQol 5-Dimensions
Table 3: Rates of participation (95% confidence intervals) in a flexible, multifaceted intervention for mild Alzheimer's disease.
Patient
(n = 157)
Caregiver
(n = 157)
Network
(n = 157)
Constructivist counselling
Initial meeting 1.00 0.99 (0.98;1.00) 0.05 (0.02;0.09)
1st follow-up meeting 0.84 (0.78;0.90) 0.85 (0.79;0.92) 0.05 (0.02;0.09)
2nd follow-up meeting 0.78 (0.72;0.85) 0.78 (0.72;0.85) 0.05 (0.02;0.09)
Network meeting 0.32 (0.25;0.39) 0.32 (0.25;0.40) 0.29 (0.22;0.36)
Final meeting 0.83 (0.78;0.89) 0.82 (0.76;0.87) 0.09 (0.04;0.13)
Telephone counselling2 0.36 (0.28;0.43) 0.80 (0.73;0.86) Not applicable
Courses
1st session 0.84 (0.78;0.90) 0.83 (0.77;0.89) 0.24 (0.17;0.30)
2nd session 0.83 (0.77;0.89) 0.82 (0.76;0.88) 0.25 (0.19;0.32)
3rd session 0.76 (0.70;0.83) 0.77 (0.70;0.84) 0.25 (0.18;0.32)
4th session 0.76 (0.70;0.83) 0.75 (0.68;0.82) 0.17 (0.10;0.23)
5th session 0.76 (0.70;0.83) 0.74 (0.66;0.80) 0.18 (0.12;0.25)
Participated in at least 3 counsellings3 0.88 (0.83;0.93) 0.91 (0.87;0.96) 0.05 (0.01;0.09)
Participated in at least 3 courses3 0.81 (0.75;0.87) 0.80 (0.74;0.87) 0.25 (0.18;0.31)
Mean duration of intervention (days) 210 (198;225)
Participation in individual meetings and sessions was determined by the individual's needs and preferences, which were assessed by the counsellor 
and participant in collaboration. Target rates were thus not necessarily 1.00 and for that reason the conventional terminology of compliance is 
avoided.
1A network comprised one to four persons but is considered here as one unit. Except for the network meetings, networks were not invited to 
attend counselling or courses; some participated in selected sessions, however. 2Either the patient or the caregiver, or both, could register for 
calls.3Participation in three sessions of constructivist counselling (of which at least two were face-to-face, not telephone) or courses was considered 
a high degree of concordance, given the flexible nature of the intervention.BMC Health Services Research 2009, 9:215 http://www.biomedcentral.com/1472-6963/9/215
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While all courses could accommodate up to 12 partici-
pants, for logistic reasons most courses were conducted
with fewer participants. The variation in professional time
used was thus due to variation in the number of partici-
pants (class size) rather than variation in course duration.
Overall, the course activity used nine hours of profes-
sional time, associated with an average of almost eight
hours of face-to-face time for patients and caregivers.
The resource utilisation associated with transportation
reflects non-productive professional and participant time.
The majority of counselling sessions (two-thirds) were
held at health care institutions; hence the greatest trans-
portation burden was on the patients and caregivers, who
each spent an average of almost eight hours on transpor-
tation between their homes and the institution. Profes-
sionals had an average transportation burden of about
four hours, which was attributable to the one-third of
counselling sessions that were conducted in patients' own
homes.
Altogether, the resource utilisation associated with the
intervention amounted to 19-21 hours each for the pro-
fessionals, patients and caregivers, and 6 hours for the net-
work contacts.
Intervention costs
The total cost of the intervention was 2,020 EUR (95% CI
1,929;2,106) per dyad. The distribution of costs was
approximately 53% in the health care sector, 17%
incurred by the patient, 21% incurred by the caregiver and
9% incurred by the patient's network. Total intervention
costs thus demonstrated an approximate 1:1 cost sharing
ratio between public and private pockets. Intervention
costs are further detailed in Table 5.
Table 4: Resource utilisation by health care personnel, patients, caregivers, and patient networks in a multifaceted intervention for 
mild Alzheimer's disease. 
Professionals' time1 Patients' time
(n = 157)
Caregivers' time
(n = 157)
Network's time2
(n = 157)
Constructivist counselling 379 (361;394) 199 (188;210) 202 (188;213) 42 (32;54)
Telephone counselling 78 (69;87) 12 (9;17) 48 (41;56) Not applicable
Courses 541 (500;580) 472 (436;501) 465 (433;495) 148 (112;195)
Transportation 269 (256;285) 463 (440;486) 458 (433;480) 169 (121;239)
Total 1,267 (1,211;1,309) 1,146 (1,085;1,205) 1,172 (1,007;1,230) 358
(272;462)
1For counselling activities and transportation, the times given are those used by the counsellor only. Time used in courses is the sum of time used 
by the counsellor, volunteers and teachers. Professionals' times are not equal to row-sum of other parties' times as the ratio of professional to 
participant was not 1:1 and unsuccessful telephone calls added to counsellor time but not to any other party's time. 2A network comprised one to 
four persons but is considered here as one unit.
Values are mean minutes of time (95% confidence interval).
Table 5: Intervention costs of multifaceted intervention for mild Alzheimer's disease. 
Indirect costs (time costs)
Direct costs1 Patient
(n = 157)
Caregiver
(n = 157)
Network
(n = 157)
Constructivist counselling 307 (294;320) 41 (39;44) 55 (50;59) 59 (30;53)
Telephone counselling 63 (57;70) 3 (2;4) 11 (9;13) Not applicable
Courses 449 (410;479) 98 (90;105) 128 (115;141) 44 (33;56)
Transportation2 251 (240;267) 205 (192;214) 233 (218;247) 73 (55;101)
Total 1,070 (1,029;1,109) 346 (325;364) 428 (397;459) 175 (148;208)
1Direct costs include time costs for counsellors plus an overhead of 20% to account for capital costs. 2Transportation costs include the direct 
taximeter or ticket cost plus the indirect costs of peoples' time.
Costs are in 2008-EUR (95% confidence interval).BMC Health Services Research 2009, 9:215 http://www.biomedcentral.com/1472-6963/9/215
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Sensitivity analysis
The study results are context-specific due to the interven-
tion's resource utilisation being dependent on e.g. infra-
structure, professional roles, participation rates and item
cost differences between markets. Figure 1 presents the
results of selected sensitivity analyses relating to the total
intervention cost. Figure 2 presents sensitivity analyses
relating to the copayment rate. First, there is a choice
between providing counselling in the patients' homes or
at health care institutions (the base-case was one-third of
sessions in the patients' homes and the remainder at insti-
tutions). Had all counselling been conducted in the
patients' homes, transportation costs would shift from
participants to the health care sector, resulting in an over-
all cost increase of, on average, 22 EUR. The copayment
rate would accordingly decrease by 0.05. A different issue
relates to the use of volunteers, who assisted professionals
in conducting patient courses, at a time cost lower than
that of health care professionals. Had no volunteers been
available, the intervention would have required more pro-
fessional staff (e.g. nurses); the cost to health care provid-
ers would then increase by an average of 85 EUR per dyad,
while the copayment rate would decrease by 0.02.
It can be argued that patient time should be valued using
a wage rate less than that of fully productive individuals.
The average impact of valuing patient time using a fixed
rate of EUR 5 per hour was a total cost reduction of EUR
142 per dyad and a copayment rate reduction of 0.04. The
average impact of increasing (or reducing) the overhead
rate by 15% was an extra (or reduced) cost of EUR 95 per
dyad, which would affect the copayment rate by -0.02
(+0.02). Finally, the impact of transportation costs was
analysed as these may vary considerably across settings
Impact of alternative scenarios of the total intervention cost of a multifaceted intervention for patients with mild Alzheimer's  disease and their primary caregivers (EUR 2,020 in base-case analysis) Figure 1
Impact of alternative scenarios of the total intervention cost of a multifaceted intervention for patients with 
mild Alzheimer's disease and their primary caregivers (EUR 2,020 in base-case analysis).
No volunteers
All counselling in patients' homes
Patient time cost EUR 5 per hour
-200 -100 0 100 200 300 400 500 600
Rural area setting
Overhead rate 35 %
EURBMC Health Services Research 2009, 9:215 http://www.biomedcentral.com/1472-6963/9/215
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due to e.g. population density and degree of specialisation
of health care institution. Had the average one-way dis-
tance (and time used on transportation) been doubled,
average participant costs would increase by EUR 511 per
dyad and the copayment rate would increase by 0.11.
Discussion
This paper reports the economic consequences to both
private and public funds of a best-bet intervention aimed
at patients with mild AD and their primary caregivers. The
intention of this work was to examine the extent to which
long-standing intervention involving not only patients
but also caregivers requires direct and indirect copayment,
which ultimately may affect equity in access to health care.
The main finding was that intervention in mild AD may
come at a relatively low cost to public funds but, at the
same time, it requires significant copayment from private
parties, which can be summarised in a cost-sharing ratio
between private and public pockets of almost 1:1.
The concurrent and detailed measurement of patient and
caregiver time required for the successful intervention in
mild AD could have been performed in other intervention
studies, yet this seems to have been neglected in studies
reported in the literature. This is in contrast to a strong
economic theoretical recommendation to include patient
and caregiver time as essential resource utilisations: cost-
ing from a societal perspective should include all resource
utilisation irrespective of who invests it. The absence of
such practice could be due to a lack of consensus regard-
ing a valid and reliable framework for costing informal
care [23-25] or to the more pragmatic issue of whether the
required effort of measurement is worthwhile relative to
the benefit.
Impact of alternative scenarios of the proportion of private copayment by patients with mild Alzheimer's disease and their pri- mary caregivers attending a multifaceted support programme (0.47 in base-case analysis) Figure 2
Impact of alternative scenarios of the proportion of private copayment by patients with mild Alzheimer's dis-
ease and their primary caregivers attending a multifaceted support programme (0.47 in base-case analysis).
No volunteers
All counselling in patients' homes
Patient time cost EUR 5 per hour
-0.06 -0.04 -0.02 0 0.02 0.04 0.06 0.08 0.1 0.12
Rural area setting
Overhead rate 35 %
Copayment rateBMC Health Services Research 2009, 9:215 http://www.biomedcentral.com/1472-6963/9/215
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From a theoretical point of view, a patient is 'occupied'
when he or she is receiving treatment and thus benefits are
sacrificed elsewhere i.e. the person cannot gain utility
from leisure time or financial earnings (if in paid employ-
ment). The minimum value of benefits forgone is, using
the opportunity cost approach, approximated by the indi-
vidual's net (if leisure time is used) or gross wage (if time
off from work is used) [26]. However, as most AD patients
are not in paid work, a hypothetical wage rate (we used
the age- and gender-matched national average) may not
reflect the true value of patients' time. We conducted sen-
sitivity analysis using a lower rate, in order to be flexible
about using the average wage rate to value patient time.
However, only a moderate impact on the overall cost-
sharing ratio was demonstrated.
The term 'concordance' was used instead of the more con-
ventional term 'compliance'. This was in consensus with
recent criticism that 'compliance' denotes the extent to
which the patient obeys the clinician rather than takes an
active role in the doctor-patient relationship [27,28]. In
this context, concordance refers to the extent to which the
collaboration between counsellor and participant results
in participation in individual components of the interven-
tion. Relating to external validity, the high rates of partic-
ipation achieved in the current trial were higher than
expected and may be explained by the fact that partici-
pants seemed to be socioeconomically advantaged rela-
tive to the average citizen and, not least, that the trial was
undertaken by highly dedicated professional staff. Lower
rates of participation may be expected in routine practice,
although that would not be expected to significantly influ-
ence the ratio of private to public costs.
There are some uncertain variables in relation to local
infrastructure - both of the health care sector (e.g. whether
relevant professionals are available at the nearest institu-
tion) and the private sector (e.g. what is the average dis-
tance from participants' homes to the institution). We
observed significant variation across the five county dis-
tricts of the trial, partly due to the free choice of participat-
ing centres to conduct counselling in the patients' homes
or at health care institutions. Similarly, some centres were
able to run highly efficient courses with all places filled,
while others suffered low volume due to location in rural
areas. Such variation affects not only total intervention
costs but also shifts costs back and forth between private
and public pockets.
Several issues are of note for community health planners
who might consider adaptation of the intervention
described here. First, the study population represents a rel-
atively resourceful group as they are at an early disease
stage and are socioeconomically advantaged. While the
study is one of the few to describe an intervention targeted
to this population, the results are not likely to be general-
isable to more severe stages of AD. Second, favourable
resource utilisation and costs are irrelevant if there is no
evidence for a clinical effect and the most useful approach
would be a synthesis of information as a cost-effectiveness
evaluation. These analyses are currently in progress. A
third remark relates to budget impact, which should be
estimated by multiplying not only the n of a target popu-
lation with the intervention cost, but should also take into
account that a certain proportion of eligible dyads reject
the invitation to participate and a further proportion drop
out after initially agreeing to participate. We have no esti-
mates on the former proportion, whereas the latter
appeared to be 0.12. Consideration should also be given
to recruitment of participants, that is, whether existing
regimens can accommodate recruitment or whether extra
resources are required to establish a regimen for screening
and inviting candidate participants. Such costs are not
included in the present analysis. Finally, start-up costs of
e.g. recruiting and educating staff, developing informa-
tional packages etc. should be expected (these were not
included in the current study).
It has long been argued that disparities in the use and
quality of care are particularly evident in long-term care,
but the first attempt to summarise this evidence was
reported only recently [29]. Much of the evidence arises
from the USA and focuses on racial disparities, where
Blacks generally appear to have a lower health care use
than Hispanics. One study, however, shows that individ-
uals with low socioeconomic status generally underuse
health care; explanatory variables appear to include
organisational and geographic characteristics of care
provision  [30]. This could be synonymous with a hypoth-
esis that requirements of considerable participant time
input and high transportation costs pose a restriction to
health care access. However, the direct question of
whether a 1:1 cost-sharing ratio between private and pub-
lic finances restricts access to care for some groups relative
to others remains unanswered.
Conclusion
Intervention in mild Alzheimer's disease can be under-
taken at a relatively low cost to public funds. However,
policy planners should pay attention to the significant pri-
vate costs associated with an intervention, which may ulti-
mately pose a threat to equity in access to health care.
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